A new report from a cannabis-focused investment bank and advisory platform provided an insight into just how much money was invested in the Canadian cannabis market so far in 2017.
The report indicates over $770 million was raised in the first half of 2017 alone, according to the numbers Viridian Capital Advisors provided Marijuana Business Daily.
“Most of the funding was directed toward the cultivation and retail sectors; the rest went to the 11 other sectors Viridian tracks, including agriculture technology, biotech/pharma and consulting services,” the reportsaid.
For comparison, last year during the same time period, the total amount of investments in cannabis totaled $43 million.

Increase in capital due to market excitement and need for expansion

Vahan Ajamian, an analyst with Beacon Securities told Marijuana Business Daily that given the shortage concerns in the Canadian cannabis industry, licenced producers (LPs) are “aiming to have as much [cannabis product] as possible to maximize market share on day one.”
In a recent interview with Investing News Network (INN) cannabis analyst at Haywood Securities Neal Gilmer explained cannabis producers in Canada are expanding production and scaling up, a direct need for this amount of heavy investment so far this year.
Gilmer said this need to ramp up was set to unsuccessfully slow down the proposed cannabis shortage set to hit Canada. Once marijuana becomes completely legal in July 2018, producers scaling up their production capacity will take more time.
“You need to make sure [the expansions are] completed and then specifically figure out their best way to scale up that productive capacity,” Gilmer told INN. “There’s no real average that you can point to because it all depends on the nature of the facility that you’re acquiring… some may take less than nine months and some are going to take more than nine months, I think it’s really on a case by case basis.”


Investor Takeaway

Excitement is continuing to show for the cannabis industry, despite a reevaluation of the market’s worth investment is still being handed out due to the potential of the recreational market. However, the medical side of the business is still quite profitable and if Gilmer’s prediction to INN comes through medical users might get recognition next year from Health Canada guaranteeing their products will not be scarce.
Editor’s note: The amount money invested in Canadian cannabis companies represents US dollars.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less